IBSA Institut Biochimique SA Sustainability Reports

IBSA Institut Biochimique SA is a Swiss multinational pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Its portfolio spans multiple therapeutic areas, including reproductive medicine, endocrinology, pain and inflammation, osteoarticular, and aesthetic medicine.

Sector: Manufacturing

Country: Switzerland

Exchange: Unlisted

LEI: 506700M9LS573HP5Q680

4 reports from 2023 to 2025

• IBSA Institut Biochimique SA 2025 Sustainability Statement
• IBSA Institut Biochimique SA 2024 Consolidated Sustainability Statement
• IBSA Institut Biochimique SA 2023 Sustainability Report
• IBSA Institut Biochimique SA 2023 ESG